Patients with A-T exhibit a spectrum of ophthalmic abnormalities, with significant oculomotor dysfunction despite relatively preserved acuity. Self-paced saccade metrics derived from VOG recordings offer a robust and interpretable measure of oculomotor function, and may serve as adjunctive biomarkers for disease monitoring and treatment evaluation. The integration of VOG into clinical assessment provides qualitative and quantitative insights into eye movement control in A-T.
Webber et al. (Wed,) studied this question.